Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_assertion description "[We found that the gene expression level of FHL2 decreased in prostate cancer compared with that of normal tissue and the gene expressions of PSA, AR and SMRT were not significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_assertion evidence source_evidence_literature NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_assertion SIO_000772 15948728 NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_assertion wasDerivedFrom befree-2016 NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_assertion wasGeneratedBy ECO_0000203 NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.
- befree-2016 importedOn "2016-02-19" NP498866.RA-Vv5Qvrm5nJfIL0WV-oFALhL_Lm6y_uWl06U5tAeH3I130_provenance.